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Diabetes mellitus produces marked abnormalities in
motor nerve conduction, but the mechanism is not
clear. In the present study we hypothesized that in
the streptozotocin (STZ)-induced diabetic rat im-
paired vasodilator function in arterioles that provide
circulation to the region of the sciatic nerve is
associated with reduced endoneural blood flow
(EBF) and that these defects precede slowing of
motor nerve conduction velocity, and thereby may
contribute to nerve dysfunction. As early as three
days after the induction of diabetes endoneural
blood flow was reduced in the STZ-induced diabetic
rat. Furthermore, after I week of diabetes acetylcho-
line-induced vasodilation was found to be impaired.
This was accompanied by an increase in the super-
oxide level in arterioles that provide circulation to
the region of the sciatic nerve as well as changes in
the level of other markers of oxidative stress
including an increase in serum levels of thiobarbi-
turic acid reactive substances and a decrease in lens
glutathione level. In contrast to the vascular related
changes that occur within I week of diabetes, motor
nerve conduction velocity and sciatic nerve Na//K
ATPase activity were significantly reduced follow-
ing 2 and 4 weeks of diabetes, respectively. These
studies demonstrate that changes in vascular func-
tion in the STZ-induced diabetic rat precede the
slowing of motor nerve conduction velocity (MNCV)
and are accompanied by an increase in superoxide
levels in arterioles that provide circulation to the
region of the sciatic nerve.
Keywords: Diabetes, vasodilation, diabetic neuropathy, acet-
ylcholine, oxygen radicals, endothelium
INTRODUCTION
The purpose of this study was to examine the
relationship between diabetes-induced reduc-
tion in sciatic nerve motor nerve conduction
velocity, endoneural blood flow and vascular
reactivity of arterioles that provide circulation
to the region of the sciatic nerve using the
streptozotocin-induced diabetic rat model.
*Corresponding author. 3 E 17 Veterans Affairs Medical Center, Iowa City, IA 52246. Tel.: (319) 338-0581 ext. 7630, Fax: (319)
339-7025, e-mail: myorek@icva.gov
131132 L.J. COPPEY et al.
In a previous study we showed that acetylcho-
line-induced endothelium-dependent vasodila-
tion of arterioles that provide blood flow to the
region of the sciatic nerve is impaired by
diabetes. Lll This defect was associated with a
decrease in neuronal blood flow of the sciatic
nerve and slowing of motor nerve conduction
velocity. In the present study we investigated
whether the impaired vasodilation of these
arterioles in diabetic rats preceded the changes
in endoneural blood flow and nerve conduction.
Diabetes mellitus produces marked abnor-
malities in motor nerve conduction, but the
mechanism is not clear. Cameron et al. reported
that hyperglycemia-induced blood flow reduc-
tion and resultant endoneural hypoxia are im-
portant factors underlying nerve conduction
deficits early in the development of diabetic
neuropathy.
[2] In their studies, they showed that
nerve blood flow was reduced as early as I week
after diabetes induction. In other studies con-
ducted with older animals reductions in nerve
blood flow were apparent and preceded the
decrease in nerve conduction velocities. TM In
the present study we examined the relationship
between changes in endoneural blood flow and
nerve conduction velocity induced by diabetes,
and the impairment in acetylcholine-induced
vasodilation in arterioles that provide circula-
tion to the region of the sciatic nerve.
The effect of diabetes on vascular reactivity
has been studied in a variety of vascular tissues.
In the aorta from several species, agonist-in-
duced endothelium-dependent vasodilation is
impaired by diabetes and by acute hyperglyce-
mia. [4-7] Similar alterations in vasodilator re-
sponses have been observed in mesenteric
arteries from diabetic rats. I8-11 Other studies
have shown reduced acetylcholine-induced va-
sodilation of the basilar artery,
[12, 13] renal inter-
lobar artery,
[14] and coronary artery
[15,16] in
diabetes. Therefore, impaired endothelial-depen-
dent vasodilation of the aorta and arteries
supplying the kidney, heart and as reported
recently by us, the region of the sciatic nerve,
is a common defect in diabetes. In this study we
report that a reduction in endoneural blood flow
in the sciatic nerve occurs as early as three days
after the induction of diabetes. Acetylcholine-
induced vasodilation by arterioles that provide
circulation to the region of the sciatic nerve is
also impaired early in diabetes and is accom-
panied by an increase in superoxide levels in
these vessels. These changes precede the slow-
ing of motor nerve conduction velocity and
the reduction in Na+/K
+ ATPase activity in the
sciatic nerve.
METHODS
Animals
Male Sprague-Dawley (Harlan Sprague Daw-
ley, Indianapolis, IN) rats 8-9 weeks of age were
used for these studies. The animals were housed
in a certified animal care facility and food and
water were provided ad libitum. All institution-
al and NIH guidelines for use of animals were
followed. Diabetes was induced by intrave-
nously injecting streptozotocin (60mg kg
-1 in
0.9% NaC1, adjusted to a pH 4.0 with 0.2M
sodium citrate). Control rats were injected with
vehicle alone. The rats were anesthetized with
methoxyflurane before injection. Diabetes was
verified 24h later by evaluating blood glucose
levels with the use of glucose oxidase reagent
strips (Boehringer-Mannheim, Indianapolis,
IN). Rats having blood glucose level of 300mg/
dl (16.7mM) or greater were considered to be
diabetic. Studies were conducted 3, 7,14, 21 and
28 days after the induction of diabetes. On the
day of the experiment rats were anesthetized
with Nembutal i.p. (50mg kg-1, Abbott Labora-
tories, North Chicago, IL). Following the deter-
mination of motor nerve conduction velocity
(MNCV) and endoneural blood flow (EBF),
the abdominal aorta was isolated and occluded
1-2cm above the branch of the common
iliac artery. Distal to the occlusion a solutionVASCULAR DYSFUNCTION IN DIABETIC NEUROPATHY 133
containing India ink with 2% gelatin
[1,17] was
injected to facilitate the identification of the
superior gluteal and internal pudendal arteries,
which arise from the common iliac artery. The
rat was then sacrificed by exsanguination, and
body temperature lowered with topical ice.
Samples of the left sciatic nerve were then taken
for determination of Na+/K+ ATPase activity,
sorbitol, fructose and myo-inositol content and
conjugated diene level. The lens was also col-
lected for determination of glutathione levels.
Levels of thiobarbituric acid reactive substances
(TBARS) in the serum and lactate/pyruvate
ratio in the aorta were also determined. Sam-
ples for blood glucose measurements were also
taken on the day of the experiment.
Motor Nerve Conduction Velocity
MNCV was determined as previously described
using a noninvasive procedure in the sciatic-
posterior tibial conducting system in a tempera-
ture controlled environment. L1,187 The left sciatic
nerve was stimulated first at the sciatic notch
and then at the Achilles tendon. Stimulation
consisted of single 0.2ms supra maximal (8V)
pulses through a bipolar electrode (Grass $44
Stimulator, Grass Medical Instruments, Quincy
MA). The evoked potentials were recorded from
the interosseous muscle with a unipolar plati-
num electrode and displayed on a digital storage
oscilloscope (model 54600A Hewlett Packard,
Rolling Meadows, IL). MNCV was calculated by
subtracting the distal from the proximal latency
measured in milliseconds from the stimulus
artifact of the take-off of the evoked potential
and the difference was divided into the distance
between the two stimulating electrodes meas-
ured in millimeters using a Vernier caliper. The
MNCV was reported in meters per second.
Endoneural Blood Flow
Immediately after determination
sciatic endoneural nutritive blood
of MNCV,
flow was
determined as described by Cameron et al. L2, 19]
The trachea was intubated for artificial ventila-
tion and a carotid cannula inserted to monitor
mean arterial blood pressure. Core temperature
was monitored using a rectal probe and tem-
perature regulated between 36 and 37C using
a heating pad and radiant heat. The right sciatic
nerve was carefully exposed by a small surgical
incision and the surrounding skin sutured to a
plastic ring. The isolated area was filled with
mineral oil, at37C to a depth of I cm to minimize
diffusion of hydrogen gas from the nerve.
The rats were then artificially ventilated. A glass
insulated platinum microelectrode (tip 2 tm)
was inserted into the sciatic nerve, proximal to
the trifurcation, and polarized at 0.25V with
respect to a reference electrode inserted subcu-
taneously into the flank of the rat. Once the
recording had stabilized the inspired air was
modified to contain 10% hydrogen gas and this
gas flow continued until the hydrogen current
recorded by the electrode had stabilized, indi-
cating equilibrium of the inspired air with ar-
terial blood. The hydrogen gas supply was then
discontinued and the hydrogen clearance curve
recorded until a baseline was achieved. The
hydrogen clearance data was fitted by computer
to a mono- or bi-exponential curve using com-
mercial software (Prism, GraphPad, San Diego,
CA) and nutritive blood flow, (ml/min/100g),
calculated using the equation described by
Young (1980) and vascular conductance, (ml/
min/100g/mm Hg) determined by dividing
nutritive blood flow by the average mean arte-
rial blood pressure. Two recordings were made
for each rat at different locations along the
nerve and the final blood flow value averaged.
Vascular Reactivity
Videomicroscopy was used to investigate in vitro
vasodilatory responsiveness of arterioles sup-
plying the region of the sciatic nerve (branches
of the superior gluteal and internal pudendal
arteries) as previously described. 11 The vessels134 L.J. COPPEY et al.
used for these studies were generally oriented
longitudinally in relation to the sciatic nerve;
however, on occasion radially oriented vessels
were also used. No differences were observed in
acetylcholine-induced vasodilation based on
the orientation of the vessel to the sciatic nerve.
Since vessels overlying the sciatic nerve were
used in this study they should be regarded as
epineurial rather than perineurial. To isolate
these vessels the common iliac was exposed
and the branch points of the internal pudendal
and superior gluteal arteries identified. The ves-
sels were then clamped, and tissue containing
these vessels and its branches dissected en
bloc. The block of tissue was immediately sub-
merged in an cooled (4C), oxygenated (20% O2,
5%CO2 and 75% N2) Krebs Henseleit physio-
logical saline solution (PSS) of the following
composition (in mM): NaC1 118, KC1 4.7,
CaC12 2.5, KHaPO4 1.2, MgSO4 1.2, NaHCO3 20,
Na2EDTA 0.026, and 5.5 glucose for dissection.
Branches of the superior gluteal and internal
pudendal arteries (50-150 tm internal diameter
and 2mm in length) were carefully dissected
and trimmed of fat and connective tissue. Both
ends of the isolated vessel segment were cannu-
lated with glass micropipettes filled with PSS
(4C), and secured with 10-0 nylon Ethilon mono-
filament sutures (Ethicon, Inc., Cornelia, GA).
The pipettes were attached to a single pressure
reservoir (initially set at 20mmHg) under con-
dition of no flow. The preparation was trans-
ferred to the stage of an inverted microscope
(CK2, Olympus, Lake Success, NY). Attached
to the microscope were a CCTV camera
(WV-BL200, Panasonic, Secaucus, NJ), video
monitor (Panasonic), and a video caliper (VIA-
100 K, Boeckeler Instruments, Inc., Tucson, AZ).
The organ chamber was connected to a rotary
pump (Masterflex, Cole Parmer Instrument
Co., Vernon Hills, IL), which continuously cir-
culated oxygenated PSS at 30ml/min and
warmed to 37C. The pressure within the vessel
was then slowly increased to 40mm Hg. At this
pressure we found that KC1 gave the maximal
constrictor response. Therefore, all the studies
were conducted at 40mm Hg. Internal diameter
(resolution of 2 tm) was measured by manually
adjusting the video micrometer. After 30min
equilibration, KC1 was added to the bath to test
vessel viability. Vessels, which failed to con-
strict more than 30%, were discarded. After
washing with PSS, vessels were incubated
for 30min in PSS and then constricted with
U46619 (10-8-10-7M) to 30-50% of passive
diameter. There was no significant difference
in the amount of U46619 required to induce
constriction in control and diabetic vessels.
Cumulative concentration-response relation-
ships were evaluated for acetylcholine (10-8-
10
-4M) using vessels from control and diabetic
rats. At the end of each acetylcholine dose
response determination sodium nitroprusside
(10-4M) was added to determine maximal
vasodilation. In a separate set of experiments ar-
terioles were isolated to determine superoxide
levels using hydroethidine as previously
described. 20
Detection of Superoxide
Hydroethidine, an oxidative fluorescent dye
was used to evaluate in situ levels of super-
oxide (O-) as described previously.I2" 21] Hydro-
ethidine is permeable to cells and in the presence
of O- is oxidized to fluorescent ethidium bro-
mide, where it is trapped by intercalating with
DNA. This method provides sensitive detection
of O- in situ. Unfixed frozen ring segments
were cut into 30%tm-thick sections and placed
on glass slides. Hydroethidine (2x 10-6M)
was topically applied to each tissue section and
coverslipped. Slides were incubated in a light
protected humidified chamber at 37C for 30
minutes. Images were obtained with a Bio-Rad
MRC-1024 laser scanning confocal microscope
equipped with a krypton/argon laser. Fluores-
cence was detected with a 585-nm long pass
filter. Normal and diabetic tissues were pro-
cessed and imaged in parallel. Laser settings
were identical for acquisition of images from
normal and diabetic specimens.VASCULAR DYSFUNCTION IN DIABETIC NEUROPATHY 135
Sciatic Nerve Sorbitol, Fructose
and Myo-inositol Content
The left sciatic nerve was removed, desheathed,
and weighed for determination of Na+/K
+
ATPase activity and conjugated diene levels
(as described below) and sorbitol, fructose and
myo-inositol content. 1"1sl For the latter deter-
mination, tissue samples were boiled for
10min in water containing c-D-methylmanno-
pyranoside as an internal standard and depro-
teinized with 0.5ml each of 0.19M Ba(OH)2 and
0.19M ZnSO4. Following centrifugation the su-
pernatant was collected, frozen, and lyophilized.
Afterwards, the samples were derivatized and
intracellular contents determined by gas-liquid
chromatography as previously described, i1,181.
Na+/K
/ ATPase Activity
Total and ouabain-inhibited Na+/K+ ATPase
activities were measured in crude homogenates
of sciatic nerve. 1"181 Sciatic nerves were de-
sheathed and homogenized in a polytron, utiliz-
ing 3 10 sec bursts, at4C in I ml of 0.2M sucrose,
0.02M Tris-HC1 buffer, pH 7.5. The samples were
then centrifuged at 100-x g for 10min at 4C.
An aliquot of the supernatant (50 gl) was add-
ed to two cuvettes containing 100mMNaC1,
10mM KC1, 2.5mM MgC12, 2mM ethylene
glycolbis(fl-aminoethyl ether)-N1-N’-tetraacetic
acid (EGTA), ImM Tris-ATP, ImM 3-(cyclohex-
ylammonium) phosphoenolpyruvate, 30mM
imidazole-HC1 buffer (pH 7.3), 0.15mM NADH,
50 gg lactate dehydrogenase, 30 gg pyruvate
kinase with or without ImM ouabain to inhibit
the ouabain-sensitive Na+/K
+ ATPase fraction.
After a 20min stabilization period, the oxidation
of NADH was recorded over a 30min period.
The activity was expressed as gmol ADP/g wet
weight/h. Each assaywas conducted in triplicate.
Additional Biological Parameters
Lactate/pyruvate ratios for the aorta were
determined using perchloric acid extracts of the
tissue and high performance liquid chromato-
graphy as previously described. 221 Lens glu-
tathione (GSH), serum TBARS and sciatic nerve
conjugated diene levelsweredetermined asmark-
ers of oxidative stress. Lens glutathione levels
were determined according to Lou et al. [23] Lens
were weighed and homogenized in cold I ml
of 10% trichloroacetic acid and centrifuged for
15min at 1000- x g. The supernatant (100 gl) was
mixed with 0.89ml of 1.0M Tris, pH 8.2, and
0.02M EDTA. Afterwards, 10 gl of dithionitro-
benzene (DTNB) was added and change in
absorbance measured at 412nm. A glutathione
standard curve (100-500 ng) was performed for
each assay. The data were recorded gg/mg wet
wt. TBARS level in serum was determined by
the method of Mihara et al. [24] as modified by
Siman and Eriksson. [25] Briefly, 200 gl of serum
was boiled in 0.75ml of phosphoric acid (0.19 M),
0.25 ml thiobarbituric acid (0.42mM) and 0.3 ml
water for 60 min. Afterwards, the samples were
precipitated with methanol/NaOH and centri-
fuged for 5 min. The supernatant was measured
fluorometrically at excitation wavelength 532nm
and emission wavelength 553nm. Standards
were prepared from malonyldialdehydbis(di-
etylacetal) and were treated identically as the
serum samples. The data was reported gg/ml
serum. Sciatic nerve conjugated diene levels
were determined according to the method of
Recknagel and Ghoshal [26] as adapted to peri-
pheral nerve tissue by Low and Nicklander.
[27]
Briefly, a segment of the sciatic nerve was extract-
ed with chloroform and methanol. The lipid ex-
tract was evaporated and redissolved in I ml
cyclohexane. Conjugated diene levels were deter-
mined by measuring the absorbance at 233nm
with extraction blanks used as references. An
extinction coefficient of 2.52 x 104M was used.
Data Analysis
The results are presented as mean +/-SE. Com-
parisons between the groups (control vs. dia-
betic) for MNCV, EBF, sciatic nerve Na+/K
+
ATPase activity, sciatic nerve sorbitol, fructose136 L.J. COPPEY et al.
and myo-inositol content, serum TBARS, sciatic
nerve conjugated diene, aorta lactate/pyruvate
ratio and lens glutathione levels were conduct-
ed using independent unpaired Student’s
tests. Dose response curves for acetylcholine for
control vs. diabetic rats were compared using
a two way repeated measures analysis of vari-
ance with autoregressive covariance struc-
ture using proc mixed program of SAS.
[1]
Whenever significant interactions were noted
for control vs. diabetic specific treatment-dose-
effects were analyzed using a Bonferoni adjust-
ment. A p value of less 0.05 was considered
significant. All computations were performed
using SAS for Windows version 6.12.
RESULTS
Body Weight and Plasma Glucose Levels
Data in Table I show that streptozotocin-induced
diabetic rats on average gained less weight than
age-matched control rats over the 3-28 day
experimental period of this study. At the time
of experimentation plasma glucose levels were
increased 3-4-fold in diabetic compared to
control rats.
Na+/K+ ATPase Activity and Sorbitol,
Fructose and Myo-inositol Content
of the Sciatic Nerve
It has been reported that Na+/K+ ATPase
activity is decreased in the sciatic nerve of
diabetic rats and this may be a contributing
factor to the slowing of motor nerve conduction
velocity. 28-31 Moreover, it has been reported
that the sorbitol content of the sciatic nerve
is increased in diabetic rats accompanied by
a reciprocal decrease in the myo-inositol
content. [18"31’32] These changes have also been
linked to nerve dysfunction in diabetic
rats. [18,31,32] In the present study we examined
the time course for the development of these
changes in the sciatic nerve of diabetic rats in
relation to slowing of motor nerve conduction
velocity and changes in vascular function. Data
in Table II demonstrate that ouabain-sensitive
Na+/K+ ATPase activity in the sciatic nerve
from diabetic rats is decreased by about 10%
following 1 week of diabetes and is signifi-
cantly reduced after 4 weeks. The fructose and
sorbitol content of the sciatic nerve is signifi-
cantly increased after 3 and 7 days of dia-
betes, respectively. In contrast, the myo-inositol
content is significantly decreased following 1
week of diabetes and after 4 weeks of diabetes
is reduced by about 65%.
Lens Glutathione Level and Serum TBARS
As a measurement of oxidative stress we
determined lens glutathione level and serum
TBARS in streptozotocin-induced diabetic rats
following 3- 28 days of diabetes. Data in Table III
demonstrate that lens glutathione levels are
significantly decreased following 1 week of
diabetes and serum TBARS are increased
TABLE Change in body weight and blood glucose levels
Animal Change in body weight (g/week) Blood glucose mg/dl
Control (n=11)* 35 4- 6 105 4- 8
Diabetic (Days)
3 (n 7) 4 4- 4 348 4-15
7 (n=6) 224-6 411 +23
14 (n 7) 17 4- 7 430 4- 26
21 (n 7) 4 4- 4 448 4-10
28 (n 7) 4- 3 458 4- 24
Data are means + S.E.M. The number of experimental observations is indicated by parenthesis.
Control rats were studied at one and three weeks.
p < 0.05 vs. control.VASCULAR DYSFUNCTION IN DIABETIC NEUROPATHY 137
TABLE II Changes in Na+/K ATPase activity and sorbitol, fructose and myo-inositol content in the sciatic nerve of
streptozotocin-induced diabetic rats
Ouabain-sensitive Content (nmol/mg wet wt)
Na//K ATPase
Animal (tmol ADP/g wet wt/h) Sorbitol Fructose Myo-inositol
Control 235.0 4-16.4 0.2 4- 0.1 0.4 4- 0.1 11.0 4-1.4
Diabetic (Days)
3 (7) 256.7 4- 31.1 0.5 4- 0.2 1.7 4- 0.2 8.7 4-1.4
7 (6) 209.1 4- 34.0 1.0 4- 0.3 2.7 4-1.0 6.1 4-1.2
14 (7) 195.54-25.0 1.04-0.1 3.1 4-0.4 5.54-1.2
21 (7) 193.7 4-15.0 1.1 4- 0.3 3.6 4- 0.5 5.1 4- 0.5
28 (7) 181.0 4-16.4 1.2 4- 0.2 3.2 4- 0.6 3.7 4- 0.4
Data are mean + S.E.M. The number of experimental observations is indicated by parenthesis.
+p < 0.05 vs. control.
TABLE III Lens glutathione level and serum TBARS in
streptozotocin-induced diabetic rats
Glutathione TBARS
Animal (tg/mg wet wt) (tg/ml serum)
Control 1.24 4- 0.22 11.9 4- 2.7
Diabetic (Days)
3 (7) 0.79 4- 0.13 14.7 4- 3.1
7 (6) 0.26 4- 0.06 14.1 4- 3.6
14 (7) 0.24 4- 0.05 16.7 4- 3.1
21 (7) 0.18 4-0.01 23.9 4- 3.2
28 (7) 0.28 4- 0.04 23.9 4- 3.4
Data are means 4- S.E.M. The number of experimental observations is
indicated by parenthesis.
p < 0.05 vs. control.
reaching significance after 3 weeks of diabetes.
We also examined conjugated diene levels in
the sciatic nerve of diabetic rats. In these stud-
ies levels of conjugated dienes were increased
significantly by about 2-3 fold as early as 1
week after the induction of diabetes (data not
shown).
Motor Nerve Conduction Velocity
and Endoneural Blood Flow
in Diabetic Rats
Data in Table IV demonstrate that motor nerve
conduction velocity was significantly decreased
after 2 weeks of diabetes. Endoneural blood
flow reported as nutritive flow (ml/min/100 g)
and conductance (ml/min/100g/mm Hg)
were significantly reduced by about 50% fol-
lowing 3 days of diabetes compared to control
rats and remained reduced after 4 weeks of
diabetes (Tab. IV). In these studies the mean ar-
terial blood pressure was not significantly dif-
ferent between the control and diabetic rats
(data not shown).
TABLE IV Time course for the development of motor nerve conduction and endoneural blood flow defects in the
streptozotocin-induced diabetic rat
MNCV Nutritive
Animal m/sec (ml/min/100 g)
Endoneural blood flow
Conductance
(ml/min/100g/mm Hg)
Control (11) 52.4 4- 2.5 18.2 4- 2.1 0.154 4- 0.016
Diabetic (Days)
3 (7) 49.6 4-1.9 9.6 4-1.5 0.084 4- 0.012
7 (6) 52.6 4- 3.9 8.6 4- 2.7 0.070 4- 0.019
14 (7) 41.3 4-1.7 10.64-2.4 0.097 4-0.011
21 (7) 38.6 4-1.6 9.9 4-1.5 0.087 4- 0.012
28 (7) 41.6 4-1.3 9.3 4-1.1 0.084 4- 0.011
Data are means 4- S.E.M. The number of experimental observations is indicated by parenthesis.
+p < 0.05 vs. control.138 L.J. COPPEY et al.
Analysis of Superoxide Levels
Data in Figure 1 show that after 2 weeks of
diabetes superoxide (O) levels as measured by
hydroethidine fluorescence are increased in
arterioles that provide circulation to the region
of the sciatic nerve compared to normal vessels.
The increase in O- levels was observed in endo-
thelial cells as well as in the smooth muscle
and adventitial cells. Analysis of O- levels in
vessels from 3 and 7-day diabetic rats suggest
that the increase in O- in diabetic rats was a
gradual process and appeared to approach
maximum after 2 weeks of diabetes. No further
increase in O levels was apparent in vessels
after 3 and 4 weeks of diabetes. As a control,
preincubating vessels from diabetic rats with
superoxide dismutase quenched the hydroethi-
dine fluorescence (data not shown).
Arteriolar Vascular Reactivity
in Diabetic Rats
Stimulated changes in vascular diameter
were measured in vitro by application of
acetylcholine.
Ilj Baseline diameter of vessels
from control and diabetic rats was similar and
the vessels were constricted to a similar
degree with U46619 (10 100 tM). Acetylcholine
produced a concentration-dependent vasodila-
tion (endothelium-dependent) in arterioles that
provide circulation to the region of the sciatic
nerve (maximum dilation 93 4- 2%) (Fig. 2,
Tab. V). At 3 days, the vascular responses to
acetylcholine were similar in diabetic and nor-
mal rats (Fig. 2, Tab. V). At 7 days, vascular
relaxation to acetylcholine was impaired in dia-
betic rats at a lower dose of acetylcholine (1 x
10-7M), however maximal relaxation was un-
changed from normal animals (Fig. 2, Tab. V).
After 14 days, vascular relaxation in diabetic rats
was significantly less at all doses of acetyl-
choline compared ’to normal rats (Fig. 2, Tab. V).
Maximal relaxation to acetylcholine was signifi-
cantly impaired in vessels from 2-week diabetic
(624-10%) compared to normal (934-2%) rats
(Tab. V). Similar results were also obtained at
3 and 4 weeks of diabetes (Tab. V). In contrast,
maximal vasodilation induced by sodium
nitroprusside (endothelium-independent) was
Control Vessels
Diabetic (2 wk.) Vessels
FIGURE Detection of superoxide levels in arterioles from control and 2-week diabetic rats. Fluorescent photomicrographs of
confocal microscopic sections of arterioles that provide circulation to the region of the sciatic nerve from three individual
control and 2-week streptozotocin-induced diabetic rats were examined on three separate days. Arterioles were labeled with the
oxidative dye hydroethidine as described in the Methods section. Recording of fluorescent were taken at identical laser and
photomultiplier settings for both control and diabetic rats.VASCULAR DYSFUNCTION IN DIABETIC NEUROPATHY 139
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FIGURE 2 Acetylcholine-induced endothelium dependent relaxation of arterioles adjacent to the sciatic nerve in control and
diabetic rats. For these studies control rats and rats with diabetes for 3, 7 and 14 days were used. Pressurized arterioles were
constricted with U46619 (30-50%) and incremental doses of acetylcholine were added to the bathing solution while recording
steady state vessel diameter. The number of experimental animals used in these studies was the same as noted in Table I. The
denotes that the response to acetylcholine was significantly attenuated (p < 0.05) in the diabetic rat.
TABLE V Relaxation of arterioles adjacent to the sciatic nerve from control and streptozotocin-induced diabetic rats: Effect on
acetylcholine-induced EDs0 and maximum response and sodium nitroprusside maximal dilation
Acetylcholine SNP
Animal ED50(nM) Max % relaxation (% relaxation)
Control (11) 564-15 934-2 954-2
Diabetic (Days)
3 (10) 71 4- 32 84 4- 6 88 4- 6
7 (9) 190 4- 42 89 4- 3 94 4- 3
14 (9) 328 4-155 62 4-10 85 4- 7
21 (10) 258 4-103 74 4- 5 85 4- 4
28 (10) 375 4-143 73 4- 8 88 4- 6
Data are means 4-S.E.M. The number of experimental observations is indicated by parenthesis.
/p < 0.05 vs. control.
not significantly affected by diabetes in these
vessels (Tab. V).
DISCUSSION
The results from these studies demonstrate
that diabetes-induced decrease in endoneural
blood flow and impairment of acetylcholine-
induced vasodilation of arterioles that provide
circulation to the region of the sciatic nerve
precedes slowing of motor nerve conduction
and decrease in Na+/K+ ATPase activity in
the sciatic nerve. Moreover, our studies show
that the generation of superoxide in vascula-
ture that provides circulation to the region of
the sciatic nerve accompanies the diabetes-in-
duced impairment in vasodilation. Other mark-
ers of oxidative stress are also increased during
this period in the streptozotocin-induced140 L.J. COPPEY et al.
diabetic rat model. These studies suggest that
vascular dysfunction may be the major factor
contributing to the development of diabetic
neuropathy.
Studies by Greene and co-workers
have shown that a reduction in Na+/K+ ATPase
activity in the sciatic nerve of diabetic rats may
be linked to an increase in the sorbitol content
and reduction in myo-inositol levels in the
sciatic nerve.
[28-31] These disturbances have
been proposed to be partially responsible for
the slowing of nerve conduction velocity in the
diabetic rat. [18,28-32] Our studies show that the
reciprocal changes in the level of sorbitol and
myo-inositol in the sciatic nerve of the diabetic
rat occurs early in diabetes and precedes the
reduction in Na+/K
/ ATPase activity. However,
in our studies slowing of motor nerve conduc-
tion velocity occurs prior to the reduction in
Na+/K+ ATPase activity in the sciatic nerve. This
suggests that the early change in nerve conduc-
tion velocity in the streptozotocin-induced dia-
betic rat is not due to a reduction in Na+/K+
ATPase activity. It is possible that the reduction
in Na+/K+ ATPase activity in the sciatic nerve
enhances neural dysfunction but that the initial
defect responsible for slowing of motor nerve
conduction velocity is caused by vascular
changes.
Cameron et al., showed that nerve blood flow
was reduced by about 40% as early as 1 week
after the induction of diabetes.TM In the same
study they also showed that acute hyperglyce-
mia maintained over the period required to
measure nerve blood flow (2-4 h) caused a 50%
reduction in blood flow. [2] Stevens et al., using
laser Doppler flux to measure nerve blood flow
found that flow was variable during the. first
two days following streptozotocin injection,
was reduced by 20% after four days of diabetes
and fell steadily until reaching a plateau at 40%
of control values after 4 weeks of diabetes. E331
Similar results were obtained in our studies.
We found that endoneural blood flow was
significantly reduced by about 50% three days
after the induction of diabetes and remained
decreased for the 4-week period of the study.
The determination of the sequential devel-
opment of vascular dysfunction in arterioles
that provide circulation to the region of the
sciatic nerve demonstrates that impairment of
endothelial-dependent vasodilation occurs ear-
ly in diabetes. One week after the induction
of diabetes, vasodilation in response to a low
dose of acetylcholine (10-7M) was significantly
decreased. However, maximum vasodilation in
response to acetylcholine was not significantly
reduced at this time, although two weeks after
the induction of diabetes vasodilation in re-
sponse to all doses of acetylcholine was sig-
nificantly reduced and maximum vasodilation
was decreased by about 30%. This effect re-
mained relatively consistent for up to 4 weeks
after the induction of diabetes. This study is
among the first to show the sequential develop-
ment of diabetes-induced changes in endoneural
blood flow, vascular reactivity and motor nerve
conduction velocity. It clearly demonstrates that
diabetes-induced impairment of endothelial-
dependent vasodilation by arterioles providing
circulation to the region of the sciatic nerve pre-
cedes the slowing of motor nerve conduction
velocity. This study also implies that impair-
ment of acetylcholine-induced vasodilation is
preceded by the reduction in endoneural blood
flow suggesting that diabetes-induced impair-
ment of endothelial dependent vasodilation in
this vascular bed is not initially related to the
defect in endoneural blood flow. One possible
explanation for this finding is that the initial
reduction in endoneural blood flow is due to
impaired vasodilation of vessels within the
nerve, which may occur earlier in diabetes.
Diabetes-induced impairment of vascular re-
activity is a common feature in both conduit
and resistance arteries from diabetic animal
models.
[34] Impaired endothelium-dependent
vasodilation in conduit and resistance arteries
in patients with insulin-dependent diabetes
has also been reported. 3s’36 However, ourVASCULAR DYSFUNCTION IN DIABETIC NEUROPATHY 141
previous studies are among the first to show
that endothelium-dependent vasodilation by
arterioles that provide circulation to the sciatic
nerve is altered by diabetes. [1] The mechanism
responsible for diabetes-induced impairment
of vascular reactivity is unknown. In the aorta,
diabetes causes the endothelium to increase the
production of both superoxide and hydrogen
peroxide leading to enhanced intracellular pro-
duction of hydroxyl radicals. 37 Studies by
Pieper and colleagues have suggested that the
generation of hydroxyl radicals may mediate
the damage caused by diabetes to the endo-
thelium of the aorta. [34’37-401 Other studies
have suggested that endothelial dysfunction in
smaller vessels may be mediated by the increased
production of free radicals and of prostaglandin
endoperoxides.14 In resistance-level arterioles
of the mesenteric circulation diabetes causes a
reduction in endothelium-dependent vaso-
dilation. [9,41] Heygate et al., reported that pre-
treatment of mesenteric arteries from diabetic
rats with indomethacin significantly improved
acetylcholine-induced vasodilation suggesting a
role for a cyclooxygenase-derived vasoconstric-
tor prostanoids in mediating diabetes-induced
vascular dysfunction in these arteries. E91 In
addition, Rodriguez-Manas et al., reported that
pretreatment of mesenteric arteries from diabetic
rats with superoxide dismutase improved
acetylcholine responsiveness suggesting that
the increased production of superoxide anions
in the vascular wall of mesenteric arteries may
also mediate vascular dysfunction. Elll Mayhan
reported similar results using basilar arteries
from diabetic rats. [42] In the latter study topical
application of superoxide dismutase partially
restored acetylcholine-induced vasodilation of
the basilar artery towards that observed in
nondiabetic rats suggesting that impaired vaso-
dilation may be related in part to enhanced
release of oxygen-derived free radicals.I42 Other
studies support a role for the production of
oxygen radicals in diabetic neuropathy. Studies
with diabetic rats incorporating the use of
anti-oxidant treatment have been shown to
prevent peripheral nerve dysfunction.
[43-46]
In our studies we have shown that acetylcho-
line-induced vasodilation of arterioles that
provide circulation to the region of the sciatic
nerve is mediated by at least two mechanisms
involving the production of nitric oxide (NO)
and endothelium-derived hyperpolarizing
factor (EDHF). 11 Therefore, impairment of
endothelium-dependent vasodilation by dia-
betes in these vessels may be mediated by
conditions that inhibit the production or bio-
activity of either or both of these vasodilators.
The present study demonstrates that diabetes
causes the production/accumulation of super-
oxide in these vessels. As discussed above, the
production of oxygen radicals has been associat-
ed with impairment of endothelium-dependent
vasodilation in both conduit and resistance
arteries. Presently, we do not know whether
the generation of superoxide or the secondary
production of hydrogen peroxide or hydroxyl
radicals by these vessels might contribute to
diabetes-induced vascular dysfunction.
In summary, these studies demonstrate that
endothelium-dependent vasodilation of arte-
rioles that provide circulation to the region of
the sciatic nerve is impaired early in diabetes
and along with reduction in endoneural blood
flow precedes the slowing of motor nerve
conduction velocity and reduction of sciatic
nerve Na+/K+ ATPase activity. In addition the
generation and accumulation of superoxide by
these arterioles coincides with the impairment
of vasodilation. These results suggest that vas-
cular dysfunction that may be caused by the
production of free oxygen radicals may be
the major factor contributing to the early devel-
opment of diabetic neuropathy.
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